JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 125 filers reported holding JOUNCE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 6.50 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2 | -99.8% | 2 | -99.2% | 0.00% | – |
| Q3 2022 | $1,000 | – | 237 | +507.7% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 39 | -100.0% | 0.00% | -100.0% |
| Q3 2021 | $1,232,000 | -67.1% | 165,863 | -69.9% | 0.00% | -50.0% |
| Q2 2021 | $3,744,000 | -27.7% | 550,562 | +9.1% | 0.00% | -33.3% |
| Q1 2021 | $5,182,000 | +5594.5% | 504,583 | +4152.0% | 0.00% | – |
| Q2 2018 | $91,000 | -71.7% | 11,867 | -17.1% | 0.00% | – |
| Q1 2018 | $321,000 | +93.4% | 14,317 | +34.4% | 0.00% | – |
| Q3 2017 | $166,000 | – | 10,656 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 1,087,961 | $2,012,728 | 1.74% |
| Opaleye Management Inc. | 2,880,000 | $5,328,000 | 1.60% |
| TANG CAPITAL MANAGEMENT LLC | 5,300,087 | $9,805,161 | 1.46% |
| Ardent Capital Management, Inc. | 923,463 | $1,708,407 | 1.23% |
| Beryl Capital Management LLC | 610,831 | $1,130,037 | 0.89% |
| Arena Investors LP | 610,639 | $1,129,682 | 0.88% |
| Omega Fund Management, LLC | 275,513 | $509,699 | 0.33% |
| Deep Track Capital, LP | 4,259,653 | $7,880,358 | 0.32% |
| PenderFund Capital Management Ltd. | 246,310 | $616 | 0.19% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 425,100 | $786,435 | 0.15% |